Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

Core Insights - Evolent Health, Inc. has granted a one-time time-based restricted stock unit award of 587,500 shares to its new Chief Financial Officer, Mr. Mario Ramos, as an inducement for his employment with the company [1] - The total grant date value of the Inducement Award is $2,350,000, with vesting scheduled over three years contingent on Mr. Ramos's continued employment [2] Company Overview - Evolent specializes in improving health outcomes for individuals with complex conditions by providing solutions that simplify and make healthcare more affordable [3] - The company serves a national base of leading payers and providers and is recognized as a top workplace in the healthcare sector [3]